$23.88
0.301.27%
가까이에: Nov 19, 4:00 PM EST
$24.08
0.502.12%
프리마켓: 5:53 AM EST

The average analyst price target for Rentokil Initial is $32, 32.9% above the current price. Of 8 analysts, 6 rate it Buy and 2 Hold. Targets range from $29 to $35. The latest change came on Jul 7, 2026, when Goldman Sachs upgraded Rentokil Initial from Neutral to Buy.
Price Target Range — 2 Quarters
Analyst Consensus — 8 Analysts
Rating Trend — Last 9 Months